New Findings from Office of Research in the Area of Inflammatory Bowel Disease Reported (Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients).

Citation metadata

Date: Jan. 26, 2022
Publisher: NewsRX LLC
Document Type: Report
Length: 561 words
Lexile Measure: 1390L

Document controls

Main content

Article Preview :

2022 JAN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in Digestive System Diseases and Conditions - Inflammatory Bowel Disease. According to news reporting originating in Columbia, South Carolina, by NewsRx journalists, research stated, "Streptococcus pneumoniae is an important pathogen responsible for severe pneumococcal diseases, including pneumonia, bacteraemia/sepsis, and meningitis. Inflammatory bowel disease [IBD] patients have an increased risk for infections due to an altered immune system and treatment with immunosuppressive medications.The aim of this study was to assess the prevalence of severe pneumococcal disease [SPD] and evaluate the impact of pneumococcal vaccination on the risk of SPD in Veterans with IBD."

The news reporters obtained a quote from the research from the Office of Research, "Subjects with IBD and SPD were identified from the VA Health Administration database using ICD9/10 codes....

Source Citation

Source Citation   

Gale Document Number: GALE|A690183416